Literature DB >> 6181801

Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.

W M Melia, H B Nunnerley, P J Johnson, R Williams.   

Abstract

Thirty patients with symptoms of the carcinoid syndrome and other symptoms not controlled by pharmacological agents were analysed with respect to the value of various treatment measures used. Tumour devascularization was carried out in 11 patients, either by surgical ligation of the main hepatic artery (6) or by percutaneous arterial embolization (5). The latter was shown to be the safer technique, both with respect to initial morbidity/mortality and other side effects. Control of flushing and diarrhoea was achieved in 80% and the technique was also repeated on one occasion with success when symptoms recurred. The use of cytotoxic drugs alone, including 5-fluorouracil, cyclophosphamide and Adriamycin produced symptomatic relief in only 4 of the 22 patients treated. They should only be considered if devascularization by arterial embolization proves impossible or cannot be repeated when symptoms recur.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181801      PMCID: PMC2011132          DOI: 10.1038/bjc.1982.208

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Response of metastatic malignant carcinoid tumor to adriamycin (NSC-123127).

Authors:  A Solomon; T Sonoda; F K Patterson
Journal:  Cancer Treat Rep       Date:  1976-03

2.  Clinical management of advanced gastrointestinal cancer.

Authors:  C G Moertel
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

3.  Clinical antitumor activity and toxicity of streptozotocin (NSC-85998).

Authors:  P S Schein; M J O'Connell; J Blom; S Hubbard; I T Magrath; P Bergevin; P H Wiernik; J L Ziegler; V T DeVita
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs.

Authors:  I M Murray-Lyon; V A Parsons; L M Blendis; J L Dawson; M O Rake; J W Laws; R Williams
Journal:  Lancet       Date:  1970-07-25       Impact factor: 79.321

5.  The malignant carcinoid syndrome.

Authors:  Z Davis; C G Moertel; D C McIlrath
Journal:  Surg Gynecol Obstet       Date:  1973-10

6.  Treatment of the carcinoid syndrome by local removal of hepatic metastases.

Authors:  J L Stephen; D G Grahame-Smith
Journal:  Proc R Soc Med       Date:  1972-05

7.  Massive hepatic resection for the carcinoid syndrome.

Authors:  R Zeegen; R Rothwell-Jackson; M Sandler
Journal:  Gut       Date:  1969-08       Impact factor: 23.059

8.  Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome.

Authors:  K Engelman; W Lovenberg; A Sjoerdsma
Journal:  N Engl J Med       Date:  1967-11-23       Impact factor: 91.245

9.  Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature.

Authors:  S S Legha; M Valdivieso; R S Nelson; R S Benjamin; G P Bodey
Journal:  Cancer Treat Rep       Date:  1977-12

10.  Treatment of carcinoid liver metastases by hepatic-artery embolisation.

Authors:  D J Allison; I M Modlin; W J Jenkins
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

View more
  5 in total

1.  [2 year interferon therapy of metastatic carcinoid tumor].

Authors:  W von Scheidt; M Böhm; I Huber; R Habersetzer; K Jacob; A Markl; G Autenrieth
Journal:  Klin Wochenschr       Date:  1990-02-15

Review 2.  Advances in neoplastic disease of the liver and biliary tract.

Authors:  P J Johnson; M L Wilkinson; J Karani
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas.

Authors:  L Makowka; A G Tzakis; V Mazzaferro; L Teperman; A J Demetris; S Iwatsuki; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1989-02

4.  Role of hepatic arterial embolisation in the carcinoid syndrome.

Authors:  P N Maton; M Camilleri; G Griffin; D J Allison; H J Hodgson; V S Chadwick
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-01

5.  Hepatic artery embolization in the treatment of intractable hypoglycaemia.

Authors:  J L Wells; D A Heath; R J West
Journal:  J R Soc Med       Date:  1990-09       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.